← Evidence map

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2023

Estimating the Risk for Secondary Cancer After Targeted α-Therapy with

Erik Leidermark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35798559